Covid and Cancer: The Surprising Connection of the Repurposed Drug Ivermectin in Treating Both

According to Google trends, online searches for Ivermectin spiked on September 2, 2021, in response to the Covid-19 pandemic fiasco. Forbes reported that Google searches here in the U.S. began to rise in mid-July, with Oklahoma, Alabama, Arkansas, Mississippi, and Louisiana leading the way.

It’s hard to stop the spread of the good news once it gets started and good news was what all of us desperately wanted as we found ourselves sidelined by the world-wide pandemic. So when folks learned that in Delhi, India, for example, the inexpensive, already FDA-approved drug, Ivermectin, obliterated 97% of Covid-19 cases in just five weeks, it’s no wonder the world sat up and took notice. And the good news kept coming. In Peru, studies showed that Ivermectin treatments resulted in excess deaths falling by 74% over a 30-day period. But there was more.

News stories like the one published in Pharmaceutical Technology (September 2020) detailed how researchers from the Biomedicine Discovery Institute in Australia discovered that Ivermectin killed SARS-CoV-2 within 48 hours — and in half that time, a mere 24 hours, there was a significant reduction of the notorious virus.

Here in America, a study published in the American Journal of Therapeutics (July/August 2021) assessing 2,438 participants, found that Ivermectin reduced the risk of death of Covid-19 infection by an average of 62% compared with no Ivermectin treatments.

Dr. Peter McCullough of Baylor University, Dr. Harvey Risch (Yale), and Dr. George Fareed (Harvard) testified before the U.S. Senate in November 2020 that early outpatient treatment protocol for COVID-19 is highly advised, and they outlined a number of ways that could be accomplished.

On December 8, 2020, Dr. Pierre Kory, ICU specialist and president of the Frontline COVID-19 Critical Care Alliance (FLCCC), testified before the U.S. Senate Committee on Homeland Security and Governmental Affairs about the lifesaving properties of Ivermectin, calling it the solution to the Pandemic and urged the government to swiftly review the expansive medical evidence on its use.

Nearly 100% effective at prevention. Dr. Kory noted, “If you take it, you will not get sick.” He went on to say that its most profound benefits are demonstrated in those patients who are hospitalized, where it is beneficial for even seriously ill patients who may be on ventilator support. Further, Ivermectin seems to help prevent the onset of “Long Hauler’s Syndrome,” the persistent and long-term issues often faced by Covid survivors with lung scarring, shortness of breath, or blood clotting disorders.

You can read Dr. Kory’s Senate testimony here which includes his recommended outpatient protocol.

So why is this highly successful 40-year-old anti-parasitic drug with an amazing track record smack dab in the middle of the Culture Covid-19 War here in the U.S.? Let’s look at the facts.

The Truth About Ivermectin

  • Ivermectin is a multi-faceted drug with anti-parasitic, anti-viral, anti-inflammatory, and anti-cancer properties
  • It was isolated from soil bacteria in Japan 40 years ago by Dr. Satoshi Omura who won the Nobel Prize for it in 2015, jointly with William C. Campbell and Tu Youyou
  • Ivermectin is already approved by the FDA as an anti-parasitic medicine and has helped save millions of lives from both parasitic and viral infections
  • It has been prescribed nearly 4 BILLION times for humans since 1987
  • It has demonstrated effectiveness in treating several different viruses including HIV, dengue, influenza, and Zika
  • It has been listed as one of the World Health Organization’s Essential Medicines
  • It is safer than aspirin and can be obtained in many countries without a prescription
  • It is 86% effective for prevention and 72% effective for early treatment of C-19 according to real-time meta-analysis of 83 studies
  • And it kills CANCER cells!
Photo by National Cancer Institute on Unsplash

Photo by National Cancer Institute on Unsplash

The Hot Debate: Is Ivermectin Safe for Both Animal and Human Use?

If you’ve seen TV ads for Heartgard or similar products that treat intestinal worms in animals and prevent heartworm disease in dogs, then you’ve discovered Ivermectin. One of two active ingredients in that product and others like it is Ivermectin.

“The derivative of avermectin (AVM), was introduced into the veterinary, agricultural and aquaculture markets for animal health in 1981. Only six years later (1987), Ivermectin was adopted and approved by the FDA as a drug for humans that was originally used for the treatment of onchocerciasis, a parasitic infection. Since then, Ivermectin has also been used to control other human diseases.” [source: “Progress in Understanding the Molecular Mechanisms Underlying the Antitumor Effects of Ivermectin,” Drug Design Development and Therapy (2020)].

NOTE: The FDA warns against taking the veterinary form of Ivermectin for human use.

It should be carefully noted that the FDA does not recommend taking the veterinary form of Ivermectin for human use. And there is no need to. Ivermectin is available by prescription for people, too. It comes in oral (tablets) and topical forms (lotions), both preparations being approved by the FDA for use in treating parasitic roundworm infections like ascariasis, head lice, and skin conditions like rosacea.

While there are currently some troubling cases of some pharmacies refusing to fill physician prescriptions for the drug, it is nonetheless unadvisable to self-administer the form of Ivermectin meant for animal use.

Always check with your healthcare practitioner to determine if this is right for you.

The Cancer Connection

Just because Covid stole the show last year, it doesn’t mean that cancer deaths declined. In fact, it was reported by the CDC that heart disease and cancer were still the leading causes of death among Americans in 2020, with Covid coming in third.

The good news is that science has been spotlighted amidst the ongoing health crisis, and a number of studies are coming to light, studies that we might not have paid attention to otherwise.

For example, Ivermectin has been demonstrably proven to have other qualities in addition to killing parasites and in being an effective treatment for Covid-19. Its antitumor effects and the ability to cause apoptosis (death) of cancer cells and the proliferation of cancer stem cells, in particular, make it an extraordinary silver bullet in any cancer patient’s arsenal.

How Does a Trained Physician Beat Terminal Cancer When He, Himself, Gets It?

In his book, Surviving Cancer, COVID-19, and Disease: The Repurposed Drug Revolution, author Dr. Justus R. Hope reveals what many physicians and privileged medical personnel “in the know” are aware of — the advantages of repurposed drugs and how to treat their own terminal cancers. In his book, Dr. Hope outlines how they did it, and how we non-medically trained citizens can do the same.

Dr. Pierre Kory (previously mentioned) and who testified before the U.S. Senate about the lifesaving properties of Ivermectin for Covid-19, has also gone on record to say that he is troubled by the fact that the FDA, CDC, and the NIH have not reviewed repurposed drugs for the treatment of cancer. He proposes the reason could be that there is no incentive to study these drugs as they are cheap and unprofitable for the drug companies.

“Repurposed drugs in my opinion should be offered in all cases of terminal cancer. They also should have been added long ago as cancer preventative agents.”

The Miracle of Anti-Parasitics

If you’ve watched my interviews with cancer survivor Joe Tippens that went viral soon after they were released, you’ll recall that it was the very inexpensive anti-parasitic drug, Fenbendazole (available without a prescription), that resulted in Joe’s extraordinary recovery from advanced Stage 4 cancer. The “Joe Tippens Protocol” is one of the most successful, sought-after, and popular alternative cancer treatments to date.

“How Joe Tippens Beat Terminal Cancer with $7 Dog Medicine”:

Part 1

Part 2

Part 3

While this is not to be considered medical advice but is instead food for thought, Ivermectin, also an anti-parasitic medication, is yet another avenue to consider when treating cancer.

Again, please always check with your healthcare practitioner to see if it is right for you.

Spend Some Time with Cancer Experts and Cancer Survivors

If you or a loved one is facing cancer, you’re certainly not alone. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the U.S., and 606,520 people are predicted to die from the disease..

I’ve personally heard those dreaded words, “You Have Cancer,” and I know how truly frightening the journey can be. But as a 35-year Stage 4 cancer survivor, I’ve learned a lot that I want to share with you. That’s why I started the Templeton Wellness Foundation. I don’t want anyone to have to go through what I did!

When you visit my website, you’ll find a wealth of information, including video interviews with cancer survivors that will encourage, enlighten, and empower you in your journey back to good health. You’ll also find some of the most extraordinary interviews with doctors and healthcare professionals from all across the world – in one-on-one conversations about their specific protocols for treating cancer patients successfully.

It’s the next best thing to sit down and talk with them yourself, person-to-person, and I think you’ll find these interviews extraordinarily beneficial.

I believe that HOPE is the first thing to employ in your fight against cancer… you’ll find it in abundance at the Templeton Wellness Foundation.


“Study finds anti-parasitic drug could kill coronavirus in 48 hours,” Pharmaceutical Technology (April 6, 2020).

A. Bryant, T.A. Lawrie, T. Dowswell, et al., Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines,” American Journal of Therapeutics (July/August 2021) Vol 18, Issue 4: e434-e460. doi: 10.1097/ MJT.0000000000001402.

R.W. Burg, B.M. Miller, E.E. Baker, et al., “Avermectins, new family of potent anthelmintic agents: producing organism and fermentation,” Antimicrobial Agents and Chemotherapy (1979);15 (3): 61–367. doi:10.1128/AAC.15.3.361.

Joshua Cohen, “Ivermectin, A 40-Year-Old Anti-Parasitic Now Embedded In A Covid-19 Culture War,” Forbes, Coronavirus (August 29, 2021).

Justice R. Hope, M.D., Ivermectin for the World. Hope Pressworks Intl LLC; 2nd ed. edition (June 15, 2021).

Justice R. Hope, M.D., Surviving Cancer, COVID-19, and Disease: The Repurposed Drug Revolution. Hope Pressworks Intl LLC (September 20, 2020).

J. Liu, K. Zhang, L. Cheng, H. Zhu, T. Zu, “Progress in Understanding the Molecular Mechanisms Underlying the Antitumor Effects of Ivermectin,” Drug Design Development and Therapy (2020); 14:285-296.

P.A. McCullough, R.J. Kelly, G. Ruocco, W.W. O’Neill, et al., “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection,” The American Journal of Medicine (August 6, 2020); doi:

Satoshi Ōmura – Facts. Nobel Prize Outreach AB (September 19, 2021).

A.D. Santin, D.E. Scheim, P.A. McCullough, M. Yagisawa, T.J. Borody, “Ivermectin: a multifaceted drug of Nobel prize – honoured distinction with indicated efficacy against a new global scourge, COVID-19,” New Microbes New Infections (2021 Aug 3);43:100924. doi: 10.1016/j.nmni.2021.100924.

Pin It on Pinterest

Share This